BACKGROUND: For patients with heart failure, reduced left ventricular ejection fraction and iron deficiency, intravenous ferric carboxymaltose administration improves quality of life and exercise capacity in the short-term and reduces hospital admissions for heart failure up to 1 year. We aimed to e...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!